23521-81-5

Basic information

• Product Name: (1,4-dioxaspiro[4.5]dec-8-yl)methanol
• CAS NO: 23521-81-5
• Molecular Weight: 172.224
• Mol File: 23521-81-5.mol
• Article Data: 51

Chemical Properties

• CAS DataBase Reference: (1,4-dioxaspiro[4.5]dec-8-yl)methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (1,4-dioxaspiro[4.5]dec-8-yl)methanol(23521-81-5)
• EPA Substance Registry System: (1,4-dioxaspiro[4.5]dec-8-yl)methanol(23521-81-5)

Safety Data

• Hazardous Substances Data: 23521-81-5(Hazardous Substances Data)

Upstream product

• 26845-47-6 methyl 1,4-dioxaspiro[4.5]decane-8-carboxylate 
• 1489-97-0 ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate 
• 3618-03-9 methyl 4-hydroxycyclohexanecarboxylate 
• 3289-28-9 ethyl cyclohexanecarboxylate 
• 93245-98-8 1,4-dioxaspiro[4.5]decane-8-carbaldehyde 
• 3685-22-1 4-hydroxycyclohexanecarboxylic acid 
• 6297-22-9 4-carbomethoxycyclohexanone 
• 107-21-1 ethylene glycol 
• 17159-79-4 ethyl 4-oxocyclohexane-1-carboxylate 
• 183-97-1 1,4,9,12-Tetraoxa-dispiro[4.2.4.2]tetradecane 
• 59691-19-9 1-Methoxy-4-(hydroxymethyl)-1,4-cyclohexadiene 
• 4746-97-8 cyclohexanedione monoethylene ketal 
• 99-76-3 methyl 4-hydroxylbenzoate 
• 38580-68-6 4-hydroxymethyl-cyclohexanone 

Downstream Products

• 132452-42-7 8-((benzyloxy)methyl)-1,4-dioxaspiro[4.5]decane 
• 17159-84-1 4-(methoxymethyl)cyclohexan-1-one 
• 1095989-98-2 (5R)-3-[4-(1,4-dioxaspiro[4.5]dec-8-ylmethoxy)benzyl]-5-methyl-1,3-oxazolidin-2-one 
• 1135032-01-7 8-{[3-(benzyloxy)phenoxy]methyl}-1,4-dioxaspiro[4.5]decane 
• 1367362-94-4 C₂₈H₃₄N₂O₅ 
• 1367362-95-5 C₂₈H₃₂F₂N₂O₅ 
• 1367362-96-6 C₂₆H₃₀N₂O₄ 
• 1367362-97-7 C₂₆H₂₈F₂N₂O₄ 
• 1367362-99-9 C₃₃H₃₉N₃O₃ 
• 1367362-98-8 C₃₃H₃₉N₃O₃ 
• 1367363-03-8 C₃₀H₃₇F₂N₃O₃ 
• 1367363-00-5 C₃₀H₃₇F₂N₃O₃ 
• 1367363-06-1 C₂₉H₃₇F₂NO₅ 
• 881210-70-4 C₃₀H₃₉F₂NO₅ 

Relevant articles and documents

A Photochemical Approach to the Taxanes

The de Mayo sequence has been applied to the inter- and intramolecular photocycloaddition of various cycloalkenes with homocamphorquinone derivatives to generate a model for the A, B, and C rings of the taxanes.A model sequence of reactions applicable to

IRAK DEGRADERS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT

PROBLEM TO BE SOLVED: To improve Δn of a liquid crystal compound. SOLUTION: One aspect of the present invention is a liquid crystal compound represented by general formula (i) [where Ri1 is a C1 to 15 alkyl group or the like, Ri2 is

1-METHYL-4-[(4-PHENYLPHENYL)SULFONYLMETHYL]CYCLOHEXYANOL AND 1-METHYL-4-[[4-(2-PYRIDYL)PHENYL]SULFONYLMETHYL]CYCLOHEXANOL COMPOUNDS AND THEIR THERAPEUTIC USE

The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain substituted 1-methyl-4-[(4-phenylphenyl)sulfonylmethyl]cyclohexanol and 1-methyl-4-[[4-(2-pyridyl)phenyl]sulfonylme